Skip to main content

Find Clinical Trials

Home
Conditions
Gallbladder Neoplasms

Clinical trial condition

Gallbladder Neoplasms

Explore clinical trials studying Gallbladder Neoplasms. Study availability and eligibility vary by location and protocol.

208 public trials 35 recruiting studies

Refine in advanced search Browse all conditions

Gallbladder Neoplasms trial results

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

Institute for Drug Development San Antonio, Texas, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

NCT00003439

Conditions: Adenocarcinoma, Adnexal Diseases, Anus Diseases, +54 more
Locations: University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

NCT00028496

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, +96 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma

NCT00238212

Conditions: Adenocarcinoma With Squamous Metaplasia of the Gallbladder, Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, +17 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma

NCT00338988

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Cancer of the Biliary Tract, +7 more
Locations: U.T. M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Cancer in the Abdomen

NCT00003046

Conditions: Adenoma, Anal Cancer, Anus Diseases, +44 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

NCT00262769

Conditions: Bile Duct Diseases, Bile Duct Neoplasms, Biliary Tract Diseases, +9 more
Locations: Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom

Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom

Addenbrooke's Hospital Cambridge, England, United Kingdom

Cumberland Infirmary Carlisle, England, United Kingdom

View all 25 locations

View Trial Details

Completed

Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer

NCT00073905

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +21 more
Locations: Kantonsspital - St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

DX-8951f in Treating Patients With Biliary Cancer

NCT00005938

Conditions: Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +17 more
Locations: University of Colorado Cancer Center Denver, Colorado, United States

Memorial Sloan-Kettering Cancer Center New York, United States

Simmons Cancer Center - Dallas Dallas, Texas, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture

NCT01320241

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +18 more
Locations: Zhongda Hospital,Southeast University Nanjing, Jiangsu, China

View Trial Details